FOXI3 promotes migration and proliferation in prostate cancer bone metastases, modulated by FGF8 - Top-Institutions - MDSpire

FOXI3 promotes migration and proliferation in prostate cancer bone metastases, modulated by FGF8

  • By

  • Angana Mukherjee

  • Daniel P. Hollern

  • William A. Byrd

  • Tyeler S. Rayburn

  • Oluwasina G. Williams

  • Carrie Knight

  • Clayton C. Yates

  • Jacqueline D. Jones

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    National Taiwan University Hospital
    National Taiwan University Hospital

    Taipei, Taiwan

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #5

    University Hospital Leipzig
    University Hospital Leipzig

    Leipzig, Germany

    Key Differentiators

    • Oncology

Original Source(s)

FOXI3 promotes migration and proliferation in prostate cancer bone metastases, modulated by FGF8

  • by Angana Mukherjee, Daniel P. Hollern, William A. Byrd, Tyeler S. Rayburn, Oluwasina G. Williams, Carrie Knight, Clayton C. Yates, Jacqueline D. Jones

  • June 18, 2026

Related Content

Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution

Artificial intelligence–enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implications

Association between metabolic syndrome components and the risk of malignant neoplasms of the brain: a nationwide cohort study